Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

1,038 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    MSF Criticized Pharmaceutical Companies For Delay In Formulating HIV Medicines For Children

    The international medical humanitarian organization, Doctors without Borders/Médecins Sans Frontières criticized pharmaceutical companies for their delays and failure to develop appropriate formulations of HIV medicines for children.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    New Drugs, Medical Devices And Cosmetics Draft Bill, 2022

    The Union Health Ministry has released a draft of The Drugs, Medical Devices and Cosmetics Bill, 2022. Once implemented, the current Drugs and Cosmetics Act, 1940...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Anand & Anand
Anand & Anand
  • Article

    NPPA Slashed Prices For 462 Branded Anti-Cancer Drugs

    Earlier On 27th February, 2019, National Pharmaceuticals Pricing Authority (the ‘NPPA') listed 42 anti-cancer drugs under 30% Trade Margin rationalization.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Pharmaceutical Patents A Threat To India's Drug Industry?

    The Indian Pharmaceutical industry is one of the largest, ranked fourth in the world in respect to the production volume.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Promotion For Research And Innovation In Pharma-MedTech

    The Government of India (GoI) has focused on encouraging manufacturing in India and introducing innovative technologies.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    Unlocking Opportunities In India's Food Processing Sector

    Marc Lessem - Senior Executive Director, North America Sales and Marketing, Nexdigm began by presenting an overview of the session.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    USFDA Approves Expanded Use Of Gardasil 9 To Include Individuals From 27 To 45 Years Of Age

    On September 05, 2018, the U.S. Food and Drug Administration approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Bevatas Is Distinct From Bevetex, Rules Delhi HC

    In January 2020, Delhi High Court dismissed an appeal by Sun Pharma Laboratories against an order passed by the trial court whereby the latter...
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Case Summary Of "Ajanta Pharma Ltd. v Theon Pharmaceuticals Ltd."

    This article summarises the judgment of High Court of Bombay dated 5th May 2017 in the case "Ajanta Pharma Ltd. v Theon Pharmaceuticals Ltd.".
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Compulsory Licensing In India Amidst The COVID 19 Pandemic: Will India Consider It?

    Compulsory licensing is closely related to pharmaceutical patents.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Copyright Infringement In The Matter Of Shivani Tibrewala v/s Rajat Mukherjee

    Defendant: Rajat Mukherjee, Welcome Friends Productions LLP, Rohit Sehtia, Amrit Sethia, S.O.I.E. Ginza Industries Ltd.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Delhi High Court Dismissed The Petition Of German Drugmaker Against Natco Pharma

    On July 11, 2019, a division bench of Judges of Delhi High Court passed an order which clearly dismisses an injunction petition filed by German drug maker, Bayer group, to protect its drug...
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Hetero's Subsidiaries Not Infringing Roxane's Patent On PhosLo

    In Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc., et al. decided by United States Court of Appeals for the Federal Circuit on November 17, 2016, Roxane had appealed against decision of district court...
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    United States District Court For The District Of New Jersey Invalidates All Asserted Claims Of US Patent No. 8822438 For Prostate Cancer Drug Zytiga (Abiraterone Acetate)

    US healthcare giant Johnson & Johnson on Oct. 26, 2018 announced that the District Court of New Jersey has issued a ruling that invalidates all the claims of J&J subsidiary Janssen's US Patent No. 8,822,438 for the prostate cancer drug Zytiga®.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Zooming Out On Compulsory Licensing Of Covid-19 Vaccines

    The unnerving bio- catastrophe, the COVID-19 pandemic has brought an array of challenges for mankind.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Green Or Brown: An Overview Of The FSSAI's Labelling Regulations

    The Delhi High Court (Court) recently ruled that all food business operators must make a complete disclosure of all components and measurements used in a food product.
    IndiaCorporate/Commercial Law
    Obhan Mason
    Obhan Mason
  • Article

    Food Regulator Mandates Food Safety Supervisor For Restaurants And License For Ecommerce Operators

    The apex food regulator, Food Safety and Standards Authority of India (hereinafter referred to as "FSSAI") has issued new regulations wherein it has made mandatory for restaurants to employ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Glenmark Pharmaceuticals Vs. Galpha Laboratories COMIP (L) No. 1063 Of 2018

    The plaintiffs highlighted that Galpha Labs has sold the impugned goods bearing the mark CLODID worth Rs 2.92 crores.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    LEGAL UPDATE: The Jan Vishwas (Amendment Of Provisions) Act, 2023

    The Jan Vishwas (Amendment of Provisions) Act, 2023 (Act), was approved by the President on 11 August 2023. Its enforcement will be determined by the Central Government through notification...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Mansukhlal Hiralal & Company
    Mansukhlal Hiralal & Company
  • Article

    Overview Of The Drugs And Cosmetics (Tenth Amendment) Rules, 2018

    The Act and the Rules have been amended several times since coming into force to meet the need of the hour.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Showing 321–340 of 1038 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics